These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1746540)

  • 41. HLA antigen and antibody association in platelet-alloimmunized patients.
    Chow MP; Lin JS; Lin CK; Kuo BI; Yung CH; Lyou JY; Hu HY; Tzeng JL; Lee TD
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):329-32. PubMed ID: 8334558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA antibodies present in the sera of sensitized patients awaiting renal transplant are also reactive to swine leukocyte antigens.
    Naziruddin B; Durriya S; Phelan D; Duffy BF; Olack B; Smith D; Howard T; Mohanakumar T
    Transplantation; 1998 Oct; 66(8):1074-80. PubMed ID: 9808494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R
    Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Removal of HLA-A,B antigens from platelets.
    Blumberg N; Masel D; Mayer T; Horan P; Heal J
    Blood; 1984 Feb; 63(2):448-50. PubMed ID: 6607083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The detection of platelet isoantibodies by membrane immunofluorescence.
    van der Schans GS; Veenhoven WA; Snijder JA; Nieweg HO
    J Lab Clin Med; 1977 Jul; 90(1):4-10. PubMed ID: 326998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR; Hammond PB; Maniscalco CA
    Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel Flow Cytometric Method for the Simultaneous Detection of Antibodies Against Platelet, Lymphocyte, And Neutrophil.
    Suh MC; Suh JS; Won DI
    Cytometry B Clin Cytom; 2018 Mar; 94(2):281-290. PubMed ID: 27631163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of HPA-1a(PLA1) and HLA antibodies on platelet function, measured with the in vitro bleeding test].
    Kretschmer V; Huss B; Feller K; Kiefel V
    Beitr Infusionsther Transfusionsmed; 1994; 32():221-4. PubMed ID: 9480093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
    Jeremiah ZA; Atiegoba AI; Mgbere O
    Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet antibody detection using frozen pooled human lymphocyte antigen-typed platelets as target cells.
    Lazarchick J; Jones TJ; Russell RJ; Hall SA
    Diagn Clin Immunol; 1988; 5(6):377-80. PubMed ID: 3219785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of HPA-1a and HLA antibodies on primary hemostasis.
    Kretschmer V; Huss B; Feller K; Ponath N; Kiefel V
    Semin Thromb Hemost; 1995; 21 Suppl 2():96-102. PubMed ID: 7660165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective elution of HLA antigens and beta 2-microglobulin from human platelets by chloroquine diphosphate.
    Kao KJ
    Transfusion; 1988; 28(1):14-7. PubMed ID: 3277320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet alloimmunization after transfusion. A prospective study in 117 heart surgery patients.
    Taaning E; Simonsen AC; Hjelms E; Svejgaard A; Morling N
    Vox Sang; 1997; 72(4):238-41. PubMed ID: 9228715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self help for platelet serologists: the Australian Platelet Antibody Workshops.
    Minchinton RM
    Transfus Med; 1992 Dec; 2(4):319-22. PubMed ID: 1339585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP).
    Wright JF; Blanchette VS; Wang H; Arya N; Petric M; Semple JW; Chia WK; Freedman J
    Br J Haematol; 1996 Oct; 95(1):145-52. PubMed ID: 8857953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identifying human leukocyte antigen (HLA)-compatible platelets using the Matchmaker programme in alloimmunised platelet-refractory patients.
    Kreuter JD
    Transfus Med; 2020 Feb; 30(1):5-6. PubMed ID: 32187786
    [No Abstract]   [Full Text] [Related]  

  • 60. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.